The use of response surface methodology for the formulation and optimization of salbutamol sulfate hydrophilic matrix sustained release tablets

References

• Fonner DE Jr, Buck JR, Banker GS. Mathematical optimization techniques in drug product design and process analysis. J Pharm Sci 1970;59:1587–1596.
   PubMed Web of Science ®Google Scholar
• Schwartz JB, Flamholz JR, Press RH. Computer optimization of pharmaceutical formulations. I. General procedure. J Pharm Sci 1973;62:1165–1170.
   PubMed Web of Science ®Google Scholar
• Schwartz JB, Flamholz JR, Press RH. Computer optimization of pharmaceutical formulations. II. Application in troubleshooting. J Pharm Sci 1973;62:1518–1519.
   PubMed Web of Science ®Google Scholar
• Bodea A, Leucuta SE. Optimization of propranolol hydrochloride sustained release pellets using a factorial design. Int J Pharm 1997;154:49–57.
   Google Scholar
• Gil EC, Colarte AI, Bataille B, Pedraz JL, Rodríguez F, Heinämäki J. Development and optimization of a novel sustained-release dextran tablet formulation for propranolol hydrochloride. Int J Pharm 2006;317:32–39.
   PubMed Web of Science ®Google Scholar
• Vijayalakshmi P, Devi VK, Narendra C, Srinagesh S. Development of extended zero-order release gliclazide tablets by central composite design. Drug Dev Ind Pharm 2008;34:33–45.
   PubMed Web of Science ®Google Scholar
• McLeod AD, Lam FC, Gupta PK, Hung CT. Optimized synthesis of polyglutaraldehyde nanoparticles using central composite design. J Pharm Sci 1988;77:704–710.
   PubMed Web of Science ®Google Scholar
• Boza A, De la Cruz Y, Jordán G, Jáuregui-Haza U, Alemán A, Caraballo I. Statistical optimization of a sustained-release matrix tablet of lobenzarit disodium. Drug Dev Ind Pharm 2000;26:1303–1307.
   PubMed Web of Science ®Google Scholar
• Chopra S, Patil GV, Motwani SK. Release modulating hydrophilic matrix systems of losartan potassium: optimization of formulation using statistical experimental design. Eur J Pharm Biopharm 2007;66:73–82.
   PubMed Web of Science ®Google Scholar
• Bodea A, Leucuta SE. Optimization of propranolol hydrochloride sustained-release pellets using Box-Behnken design and desirability function. Drug Dev Ind Pharm 1998;24:145–155.
   PubMed Web of Science ®Google Scholar
• Bodea A, Leucuta SE. Optimization of hydrophilic matrix tablets using a d-optimal design. Int J Pharm 1997;153:247–255.
   Web of Science ®Google Scholar
• Chang JS, Huang YB, Hou SS, Wang RJ, Wu PC, Tsai YH. Formulation optimization of meloxicam sodium gel using response surface methodology. Int J Pharm 2007;338:48–54.
   PubMed Web of Science ®Google Scholar
• Huang YB, Tsai YH, Lee SH, Chang JS, Wu PC. Optimization of pH-independent release of nicardipine hydrochloride extended-release matrix tablets using response surface methodology. Int J Pharm 2005;289:87–95.
   PubMed Web of Science ®Google Scholar
• Miyamoto Y, Ogawa S, Miyajima M, Matsui M, Sato H, Takayama K et al. An application of the computer optimization technique to wet granulation process involving explosive growth of particles. Int J Pharm 1997;149:25–36.
   Google Scholar
• Singh B, Kumar R, Ahuja N. Optimizing drug delivery systems using systematic “design of experiments.” Part I: fundamental aspects. Crit Rev Ther Drug Carrier Syst 2005;22:27–105.
   PubMed Web of Science ®Google Scholar
• Singh B, Kumar R, Ahuja N. Optimizing drug delivery systems using systematic “design of experiments.” Part I: fundamental aspects. Crit Rev Ther Drug Carrier Syst 2005;22:27–105.
   PubMed Web of Science ®Google Scholar
• Chuo WH, Tsai TR, Hsu SH, Cham TM. Development of nifedipine-loaded albumin microspheres using a statistical factorial design. Int J Pharm 1996;134:247–251.
   Web of Science ®Google Scholar
• Aslan N. Application of response surface methodology and central composite rotatable design for modeling and optimization of a multi-gravity separator for chromite concentration. Powder Technol 2008;185:80–86.
   Web of Science ®Google Scholar
• Draper NR, Lin DKJ. Response surface designs. In: Ghosh S, Rao CR, eds. Design and Analysis of Experiments. Amsterdam; New York: North-Holland; 1996, pp. 343–375.
   Google Scholar
• Escudero JJ, Ferrero C, Jiménez-Castellanos MR. Compaction properties, drug release kinetics and fronts movement studies from matrices combining mixtures of swellable and inert polymers: effect of HPMC of different viscosity grades. Int J Pharm 2008;351:61–73.
   PubMed Web of Science ®Google Scholar
• Ranga Rao KV, Padmalatha Devi K. Swelling controlled-release systems: recent developments and applications. Int J Pharm 1988;48:1–13.
   Google Scholar
• Vueba ML, Batista de Carvalho LA, Veiga F, Sousa JJ, Pina ME. Role of cellulose ether polymers on ibuprofen release from matrix tablets. Drug Dev Ind Pharm 2005;31:653–665.
   PubMed Web of Science ®Google Scholar
• Solinís MA, Lugará S, Calvo B, Hernández RM, Gascón AR, Pedraz JL. Release of salbutamol sulphate enantiomers from hydroxypropylmethylcellulose matrices. Int J Pharm 1998;161:37–43.
   Web of Science ®Google Scholar
• Murthy SN, Rani S, Hiremath R. Formulation and evaluation of controlled-release transdermal patches of theophylline–salbutamol sulfate. Drug Dev Ind Pharm 2001;27:1057–1062.
   PubMed Web of Science ®Google Scholar
• Conti S, Maggi L, Segale L, Ochoa Machiste E, Conte U, Grenier P et al. Matrices containing NaCMC and HPMC 2. Swelling and release mechanism study. Int J Pharm 2007;333:143–151.
   PubMed Web of Science ®Google Scholar
• Baveja SK, Rao KVR. Sustained release tablet formulation of centperazine. Int J Pharm 1986;31:169–174.
   Web of Science ®Google Scholar
• Baveja SK, Ranga Rao KV, Padmalatha Devi K. Zero-order release hydrophilic matrix tablets of [beta]-adrenergic blockers. Int J Pharm 1987;39:39–45.
   Web of Science ®Google Scholar
• Khan GM, Jiabi Z. Formulation and in vitro evaluation of ibuprofen–Carbopol 974P-NF controlled release matrix tablets. III: Influence of co-excipients on release rate of the drug. J Control Release 1998;54:185–190.
   PubMed Web of Science ®Google Scholar
• Durrani MJ, Andrews A, Whiteker R, Banner SC. Studies on drug release kinetics from carbomer matrices. Drug Dev Ind Pharm 1994;20:2439–2447.
   Web of Science ®Google Scholar
• Huang LL, Schwartz JB. Studies on drug release from a carbomer tablet matrix. Drug Dev Ind Pharm 1995;21:1487–1501.
   Web of Science ®Google Scholar
• Talukdar MM, Michoel A, Rombaut P, Kinget R. Comparative study on xanthan gum and hydroxypropylmethyl cellulose as matrices for controlled-release drug delivery I. Compaction and in vitro drug release behaviour. Int J Pharm 1996;129:233–241.
   Web of Science ®Google Scholar
• Sujja-areevath J, Munday DL, Cox PJ, Khan KA. Relationship between swelling, erosion and drug release in hydrophilic natural gum mini-matrix formulations. Eur J Pharm Sci 1998;6:207–217.
   PubMed Web of Science ®Google Scholar
• Majid Khan G, Zhu JB. Ibuprofen release kinetics from controlled-release tablets granulated with aqueous polymeric dispersion of ethylcellulose II: influence of several parameters and coexcipients. J Control Release 1998;56:127–134.
   PubMed Web of Science ®Google Scholar
• Tsai T, San YP, Ho HO, Wu JS, Sheu MT. Film-forming polymer-granulated excipients as the matrix materials for controlled release dosage forms. J Control Release 1998;51:289–299.
   PubMed Web of Science ®Google Scholar
• Salbutamol. Martindale: The Complete Drug Reference, updated November 22, 2008; http://www.medicinescomplete.com/mc/martindale/current/ms-2104-z.htm. Accessed February 21, 2009.
   Google Scholar
• Calverley PMA. Modern treatment of chronic obstructive pulmonary disease. Eur Respir J 2001;18:60s–66s.
   Google Scholar
• Kikuchi S, Takayama K. Multivariate statistical approach to optimizing sustained-release tablet formulations containing diltiazem hydrochloride as a model highly water-soluble drug. Int J Pharm 2010;386:149–155.
   PubMed Web of Science ®Google Scholar
• Qiu Y, Flood K, Marsh K, Carroll S, Trivedi J, Arneric SP et al. Design of sustained-release matrix systems for a highly water-soluble compound, ABT-089. Int J Pharm 1997;157:43–52.
   Google Scholar
• Box GEP, Wilson KB. On the experimental attainment of optimum conditions. J Royal Stat Soc Ser B 1951;13:1–45.
   Google Scholar
• Lewis GA. Optimization methods. In: Swarbrick J, NetLibrary I, eds. Encyclopedia of Pharmaceutical Technology. Informa Healthcare; NewYork 2002.
   Google Scholar
• Mathworks I. Model-Based Calibration Toolbox™ 3. Model Browser User’s Guide. Mathworks Inc. Web site 2009: http://www.mathworks.com/access/helpdesk/help/pdf_doc/mbc/mbcmodel.pdf. Accessed November 20, 2009.
   Google Scholar
• Moore JW, Flanner HH. Mathematical comparison of dissolution profiles. Pharm Technol 1996;20:64–74.
   Google Scholar
• Yeole P, Galgatte U, Babla I, Nakhat P. Design and evaluation of xanthan gum-based sustained release matrix tablets of diclofenac sodium. Indian J Pharm Sci 2006;68:185–189.
   Google Scholar
• Rowe RC, Sheskey PJ, Owen SC, American Pharmacists Association. Handbook of Pharmaceutical Excipients. London; Greyslake, IL; Washington, DC: Pharmaceutical Press; American Pharmacists Association; 2006.
   Google Scholar
• Sadeghi F, Ford JL, Rubinstein MH, Rajabi-Siahboomi AR. Comparative study of drug release from pellets coated with HPMC or Surelease. Drug Dev Ind Pharm 2000;26:651–660.
   PubMed Web of Science ®Google Scholar
• Rekhi GS, Porter SC, Jambhekar SS. Factors affecting the release of propranolol hydrochloride from beads coated with aqueous polymeric dispersions. Drug Dev Ind Pharm 1995;21:709–729.
   Web of Science ®Google Scholar
• Lubrizol Advanced Materials I. Lubrizol pharmaceutical polymers for controlled release tablets and capsules. Pharmaceutical Bulletin October 2009: http://www.lubrizol.com/WorkArea/linkit.aspx?LinkIdentifier=id&ItemID=33648. Accessed November 20, 2009.
   Google Scholar